Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,112 | -772 | -17,219 | -14,748 | -8,804 |
| Depreciation Amortization | 233 | 112 | 269 | 199 | 132 |
| Accounts receivable | N/A | N/A | 1,782 | 1,801 | 189 |
| Accounts payable and accrued liabilities | -610 | -280 | 147 | -87 | 125 |
| Other Working Capital | -1,037 | 800 | 430 | -56 | -1,070 |
| Other Operating Activity | -3,744 | -4,112 | 5,479 | 4,963 | 2,931 |
| Operating Cash Flow | $-10,270 | $-4,252 | $-9,112 | $-7,928 | $-6,497 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,035 | -6,979 | -14,244 | N/A | N/A |
| PPE Investments | -155 | -141 | -1,433 | -462 | -71 |
| Other Investing Activity | 0 | 0 | 34 | 0 | 0 |
| Investing Cash Flow | $-6,190 | $-7,120 | $-15,643 | $-462 | $-71 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 24,563 | 24,204 | 10,108 |
| Financing Cash Flow | $N/A | $N/A | $24,563 | $24,204 | $10,108 |
| Beginning Cash Position | 18,974 | 18,974 | 19,166 | 19,166 | 19,166 |
| End Cash Position | 2,514 | 7,602 | 18,974 | 34,980 | 22,706 |
| Net Cash Flow | $-16,460 | $-11,372 | $-192 | $15,814 | $3,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,270 | -4,252 | -9,112 | -7,928 | -6,497 |
| Capital Expenditure | -155 | -141 | -1,433 | -462 | -71 |
| Free Cash Flow | -10,425 | -4,393 | -10,545 | -8,390 | -6,568 |